To access this element change to forms mode OFF

Archived Grant Opportunity View - GO4641

MRFF – EPCDR Initiative – 2020 Neurofibromatosis Research Grant Opportunity

Contact Details

NHMRC Research Help Centre

:

:

GO ID:
GO4641
Agency:
National Health and Medical Research Council (NHMRC)
Close Date & Time:
7-Apr-2021 5:00 pm (ACT Local Time)
Show close time for other time zones
Co-sponsored with:
Department of Health
Internal Reference ID:
round/74
Primary Category:
231013 - Medical Research
Publish Date:
10-Feb-2021
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Targeted or Restricted Competitive

Description:

The Medical Research Future Fund (MRFF) – Emerging Priorities and Consumer Driven Research Initiative is designed to support high quality biomedical, clinical, health services and/or population health research that improves patient care, translates new discoveries into clinical practice, new diagnoses, treatments and cures for those suffering from rare and debilitating conditions and encourages joint collaboration of consumers and researchers in undertaking research in emerging priority areas. 

The MRFF – 2020 Neurofibromatosis Research Grant Opportunity will provide grants of financial assistance to support Australian medical research projects that:

  • Stream 1: build knowledge of the factors that drive variation in the clinical presentation of neurofibromatosis for the purpose of generating new interventions
  • Stream 2: use clinical trials to test the effectiveness of new interventions for the treatment of neurofibromatosis.

 

The intended outcome of the research is to improve the health and wellbeing of Australians by generating knowledge that will lead to new interventions that reduce the clinical impact of neurofibromatosis. 

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.

Further information on the Medical Research Future Fund is available from the Department of Health website.

Eligibility:

Applications will only be accepted from NHMRC approved Administering Institutions. A list of NHMRC approved Administering Institutions is available from the GrantConnect GO Documents and from the NHMRC’s Administering Institutions list on the NHMRC website.

Applications must satisfy all the requirements set out in the Medical Research Future Fund (MRFF) – Emerging Priorities and Consumer Driven Research Initiative – 2020 Neurofibromatosis Research Grant Opportunity Guidelines

Grant Activity Timeframe:

June 2026

Total Amount Available (AUD):

$7,000,000.00

Estimated Grant Value (AUD):

From $0.00 to $7,000,000.00

Instructions for Application Submission:

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Administering Institution that will submit the application to identify any specific requirements that the Institution might have.

Applications must be submitted electronically using NHMRC’s online granting system (Sapphire).

Other Instructions:

Minimum Data closes at 5:00 pm (ACT Local Time) on 24 March 2021

Questions should be submitted no later than 1:00 pm (ACT Local Time) on 31 March 2021

Contact Details

NHMRC Research Help Centre

:

: